Spots Global Cancer Trial Database for plinabulin
Every month we try and update this database with for plinabulin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer | NCT03575793 | Lung Cancer SCLC | Nivolumab Plinabulin Ipilimumab | 18 Years - | Big Ten Cancer Research Consortium | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 | NCT03102606 | Chemotherapy-in... | Plinabulin Pegfilgrastim Saline Placebo D5W Placebo | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT02812667 | Non-small Cell ... | Nivolumab + Pli... | 18 Years - | University of California, San Diego | |
| Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer | NCT02846792 | ALK Gene Transl... EGFR Activating... Recurrent Non-S... ROS1 Gene Trans... Stage IIIB Non-... Stage IV Non-Sm... | Nivolumab Plinabulin | 18 Years - | University of Washington | |
| Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia | NCT03294577 | Chemotherapy-in... | Pegfilgrastim Plinabulin D5W Placebo Docetaxel, doxo... | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT02812667 | Non-small Cell ... | Nivolumab + Pli... | 18 Years - | University of California, San Diego | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 | NCT04345900 | Chemotherapy-in... | Plinabulin Pegfilgrastim | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies | NCT04902040 | Advanced Bladde... Advanced Lung N... Advanced Malign... Advanced Melano... Advanced Merkel... Advanced Renal ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Stage III Bladd... Stage III Lung ... Stage III Renal... Stage IIIA Blad... Stage IIIA Lung... Stage IIIB Blad... Stage IIIB Lung... Stage IIIC Lung... Stage IV Bladde... Stage IV Lung C... Stage IV Renal ... Stage IVA Bladd... Stage IVA Lung ... Stage IVB Bladd... Stage IVB Lung ... | Atezolizumab Avelumab Durvalumab Nivolumab Pembrolizumab Plinabulin Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) | NCT05130827 | Multiple Myelom... | Plinabulin | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies | NCT04902040 | Advanced Bladde... Advanced Lung N... Advanced Malign... Advanced Melano... Advanced Merkel... Advanced Renal ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Stage III Bladd... Stage III Lung ... Stage III Renal... Stage IIIA Blad... Stage IIIA Lung... Stage IIIB Blad... Stage IIIB Lung... Stage IIIC Lung... Stage IV Bladde... Stage IV Lung C... Stage IV Renal ... Stage IVA Bladd... Stage IVA Lung ... Stage IVB Bladd... Stage IVB Lung ... | Atezolizumab Avelumab Durvalumab Nivolumab Pembrolizumab Plinabulin Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Plinabulin iv Solution in Prevention of TAC Induced Neutropenia | NCT04227990 | Chemotherapy-in... | Plinabulin Pegfilgrastim Docetaxel, doxo... | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) | NCT05599789 | Non Small Cell ... | Pembrolizumab i... | 18 Years - | Peking Union Medical College Hospital | |
| Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) | NCT05130827 | Multiple Myelom... | Plinabulin | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Plinabulin iv Solution in Prevention of TAC Induced Neutropenia | NCT04227990 | Chemotherapy-in... | Plinabulin Pegfilgrastim Docetaxel, doxo... | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer | NCT02846792 | ALK Gene Transl... EGFR Activating... Recurrent Non-S... ROS1 Gene Trans... Stage IIIB Non-... Stage IV Non-Sm... | Nivolumab Plinabulin | 18 Years - | University of Washington | |
| Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) | NCT05599789 | Non Small Cell ... | Pembrolizumab i... | 18 Years - | Peking Union Medical College Hospital | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 | NCT03102606 | Chemotherapy-in... | Plinabulin Pegfilgrastim Saline Placebo D5W Placebo | 18 Years - | BeyondSpring Pharmaceuticals Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
